Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 5
1967 1
1968 3
1969 5
1970 9
1971 8
1972 17
1973 8
1974 11
1975 7
1976 12
1977 6
1978 8
1979 7
1980 5
1981 11
1982 6
1983 8
1984 4
1985 8
1986 4
1987 5
1988 3
1989 6
1990 11
1991 10
1992 15
1993 15
1994 8
1995 5
1996 18
1997 21
1998 24
1999 18
2000 29
2001 37
2002 45
2003 52
2004 70
2005 51
2006 67
2007 55
2008 65
2009 63
2010 82
2011 73
2012 69
2013 82
2014 84
2015 89
2016 75
2017 56
2018 61
2019 66
2020 57
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

1,541 results
Results by year
Filters applied: . Clear all
Page 1
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease.
Bermejo F, Aguas M, Chaparro M, Domènech E, Echarri A, García-Planella E, Guerra I, Gisbert JP, López-Sanromán A; en representación de GETECCU. Bermejo F, et al. Gastroenterol Hepatol. 2018 Mar;41(3):205-221. doi: 10.1016/j.gastrohep.2017.11.007. Epub 2018 Jan 19. Gastroenterol Hepatol. 2018. PMID: 29357999 Review. English, Spanish.
Thiopurines (azathioprine and mercaptopurine) are widely used in patients with inflammatory bowel disease. ...They are mainly used to maintain remission in steroid-dependent disease or with ciclosporin to control a severe ulcerative colitis flare-up, as well …
Thiopurines (azathioprine and mercaptopurine) are widely used in patients with inflammatory bowel disease. ...They are mainly used to …
Long-term efficacy and safety of azathioprine in ulcerative colitis.
Sood R, Ansari S, Clark T, Hamlin PJ, Ford AC. Sood R, et al. J Crohns Colitis. 2015 Feb;9(2):191-7. doi: 10.1093/ecco-jcc/jju010. J Crohns Colitis. 2015. PMID: 25518053 Clinical Trial.
BACKGROUND AND AIMS: Azathioprine (AZA) is an established treatment for ulcerative colitis (UC).However, controversy exists regarding its efficacy in inducing and maintaining clinical remission, and long-term data are lacking. ...
BACKGROUND AND AIMS: Azathioprine (AZA) is an established treatment for ulcerative colitis (UC).However, controversy ex …
Ulcerative colitis: diagnosis and treatment.
Langan RC, Gotsch PB, Krafczyk MA, Skillinge DD. Langan RC, et al. Am Fam Physician. 2007 Nov 1;76(9):1323-30. Am Fam Physician. 2007. PMID: 18019875 Free article. Review.
Ulcerative colitis is a chronic disease with recurrent symptoms and significant morbidity. ...Longstanding ulcerative colitis is associated with an increased risk of colon cancer. ...
Ulcerative colitis is a chronic disease with recurrent symptoms and significant morbidity. ...Longstanding ulcerative
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A, McDonald JW, Macdonald JK. Timmer A, et al. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000478. doi: 10.1002/14651858.CD000478.pub2. Cochrane Database Syst Rev. 2007. PMID: 17253451 Updated. Review.
BACKGROUND: Maintenance of remission is a major issue in inflammatory bowel disease. In ulcerative colitis, the evidence for the effectiveness of azathioprine and 6-mercaptopurine for the maintenance of remission is still controversial. OBJECTIVES: To assess …
BACKGROUND: Maintenance of remission is a major issue in inflammatory bowel disease. In ulcerative colitis, the evidence for t …
[Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
Kull E, Beau P. Kull E, et al. Gastroenterol Clin Biol. 2002 Apr;26(4):367-71. Gastroenterol Clin Biol. 2002. PMID: 12070412 Free article. French.
Azathioprine was discontinued early for side-effect in 8 (26.7%) patients with ulcerative colitis and in 8 (21.1%) patients with Crohn's disease (NS). In patients treated at least 6 months by azathioprine, clinical remission rates were 77.3% and 70% fo
Azathioprine was discontinued early for side-effect in 8 (26.7%) patients with ulcerative colitis and in 8 (21.1%) pati
Azathioprine, mucosal healing in ulcerative colitis, and the chemoprevention of colitic cancer: a clinical-practice-based forecast.
Actis GC, Pellicano R, David E, Sapino A. Actis GC, et al. Inflamm Allergy Drug Targets. 2010 Mar;9(1):6-9. doi: 10.2174/187152810791292863. Inflamm Allergy Drug Targets. 2010. PMID: 19906011
The development of colorectal cancer in ulcerative colitis is a function of disease duration, with the risk approaching 14% at 25 years. ...By contrast, endoscopic and clinical data in our hands have continued to suggest such a role: of a cohort of ulcerative
The development of colorectal cancer in ulcerative colitis is a function of disease duration, with the risk approaching 14% at …
Clinical features and course of ulcerative colitis diagnosed in asymptomatic subjects.
Park SK, Ye BD, Yang SK, Kim SO, Kim J, Kim JW, Park SH, Yang DH, Jung KW, Kim KJ, Byeon JS, Myung SJ, Kim JH. Park SK, et al. J Crohns Colitis. 2014 Oct;8(10):1254-60. doi: 10.1016/j.crohns.2014.03.002. Epub 2014 Mar 21. J Crohns Colitis. 2014. PMID: 24662395
BACKGROUND AND AIMS: Although some ulcerative colitis (UC) patients are diagnosed when they do not have any UC-related symptoms, clinical features and prognosis of UC diagnosed in asymptomatic patients remain unclear. ...At diagnosis, proctitis was noted in 11 patie …
BACKGROUND AND AIMS: Although some ulcerative colitis (UC) patients are diagnosed when they do not have any UC-related symptom …
Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.
Aloi M, DʼArcangelo G, Bramuzzo M, Gasparetto M, Martinelli M, Alvisi P, Illiceto MT, Valenti S, Distante M, Pellegrino S, Gatti S, Arrigo S, Civitelli F, Martelossi S; SIGENP IBD Working Group. Aloi M, et al. Inflamm Bowel Dis. 2016 Jul;22(7):1647-54. doi: 10.1097/MIB.0000000000000828. Inflamm Bowel Dis. 2016. PMID: 27271489
BACKGROUND: We aimed at describing the efficacy of azathioprine (AZA) in pediatric ulcerative colitis, comparing the outcomes of early (0-6 months) versus late (6-24 months) initiation of therapy. METHODS: Children with ulcerative colitis treate …
BACKGROUND: We aimed at describing the efficacy of azathioprine (AZA) in pediatric ulcerative colitis, comparing the ou …
Contemporary Management of Ulcerative Colitis.
Vanga R, Long MD. Vanga R, et al. Curr Gastroenterol Rep. 2018 Mar 27;20(3):12. doi: 10.1007/s11894-018-0622-0. Curr Gastroenterol Rep. 2018. PMID: 29589185 Review.
PURPOSE OF REVIEW: We discuss the newest evidence-based data on management of ulcerative colitis (UC). We emphasize risk-stratification, optimizing medical therapies, and surgical outcomes of UC. ...Data on optimization of infliximab show the superiority of combinat …
PURPOSE OF REVIEW: We discuss the newest evidence-based data on management of ulcerative colitis (UC). We emphasize risk-strat …
Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid-dependent ulcerative colitis.
Lopez-Sanroman A, Bermejo F, Carrera E, Garcia-Plaza A. Lopez-Sanroman A, et al. Aliment Pharmacol Ther. 2004 Jul 15;20(2):161-6. doi: 10.1111/j.1365-2036.2004.02030.x. Aliment Pharmacol Ther. 2004. PMID: 15233695 Free article.
BACKGROUND: The efficacy of azathioprine in the management of steroid-dependent ulcerative colitis is taken for granted. ...AIM: To assess the efficacy and safety of thiopurinic immunomodulators in strictly defined steroid-dependent ulcerative colit
BACKGROUND: The efficacy of azathioprine in the management of steroid-dependent ulcerative colitis is taken for granted …
1,541 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page